Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Cash & Current Investments (2016 - 2025)

Cellectis (CLLS) has 7 years of Cash & Current Investments data on record, last reported at $101.1 million in Q4 2022.

  • For Q4 2022, Cash & Current Investments fell 45.53% year-over-year to $101.1 million; the TTM value through Dec 2022 reached $101.1 million, down 45.53%, while the annual FY2022 figure was $101.1 million, 45.53% down from the prior year.
  • Cash & Current Investments reached $101.1 million in Q4 2022 per CLLS's latest filing, down from $185.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $451.5 million in Q4 2018 and bottomed at $101.1 million in Q4 2022.
  • Average Cash & Current Investments over 4 years is $244.9 million, with a median of $213.4 million recorded in 2020.
  • Peak YoY movement for Cash & Current Investments: surged 52.03% in 2018, then plummeted 45.53% in 2022.
  • A 4-year view of Cash & Current Investments shows it stood at $451.5 million in 2018, then plummeted by 46.59% to $241.1 million in 2020, then decreased by 23.02% to $185.6 million in 2021, then plummeted by 45.53% to $101.1 million in 2022.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $101.1 million in Q4 2022, $185.6 million in Q4 2021, and $241.1 million in Q4 2020.